Investigates the role of CSE in oxidative cardiac injury due to iron overload, suggesting therapeutic avenues.
Objectives Iron overload (IO) cardiomyopathy is a major cause of mortality in patients with iron overload disorders. This study investigates the role of cystathionine γ-lyase (CSE), a key enzyme in the transsulfuration pathway for cysteine and hydrogen sulfide (H2S) production, in iron-induced oxidative cardiac injury.Methods We investigated the effects of CSE on oxidative stress, metabolic dysregulation, and cardiac remodeling using in vivo mouse models of chronic iron overload and in vitro ferric citrate (FAC)-treated cardiomyocytes.Results Genetic deletion of Cth (encoding CSE) in mice exacerbated iron overload-induced cardiac hypertrophy, systolic dysfunction, and interstitial fibrosis. These effects correlated with reduced expression of the cysteine transporter SLC7A11, impaired glutathione (GSH) synthesis, and suppression of the nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1)/glutathione peroxidase 4 (GPX4) antioxidant signaling pathway. Conversely, CSE overexpression in cardiomyocytes restored SLC7A11 stability, and suppressed reactive oxygen species (ROS) production through the Nrf2/HO-1/GPX4 pathway, thereby attenuating iron-mediated oxidative damage. Mechanistically, CSE deficiency disrupted both cysteine uptake via SLC7A11and cysteine production via transsulfuration pathway, inducing a self-reinforcing cycle of oxidative stress.Conclusion These findings demonstrate that the CSE-transsulfuration pathway serves as a crucial regulator of cysteine metabolism and antioxidant signaling in cardiomyocytes, presenting a potential therapeutic target in iron-induced cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: